Bandingkan Harga & Kinerja Garudafood Putra Putri Jaya Tbk. (GOOD) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Garudafood Putra Putri Jaya Tbk. dan Organon Pharma Indonesia Tbk.: Garudafood Putra Putri Jaya Tbk. diperdagangkan di Rp316 (kapitalisasi pasar 11,59 T, volume 24 jam 110,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Garudafood Putra Putri Jaya Tbk. jauh lebih besar — sekitar 111× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GOOD | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 11,59 T | 104,4 M |
Volume | 110,1 rb | — |
Lot | 1,1 rb | — |
Perputaran | 34,47 jt | — |
Harga Rata-rata | 313,08 | — |
Nilai Transaksi | 34,47 jt | — |
Harga Ekuilibrium Indikatif | 316 | — |
Volume Ekuilibrium Indikatif | 17 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Garudafood Putra Putri Jaya Tbk.
PT Garudafood Putra Putri Jaya (the Company) was established in Indonesia based on Notarial Deed No. 21 of Dra. Selawati Halim, S.H., dated August 24, 1994 under the name of PT Garuda Putra Putri Jaya. Based on Notarial Deed No. 12 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated November 7, 2000, the Company merged with PT Tudung Putra Jaya and PT Garudafood Jaya and subsequentlychanged its name from PT Garuda Putra Putri Jaya to PT Garudafood Putra Putri Jaya based on Notarial Deed No. 44 of Popie Savitri Martosuhardjo Pharmanto, S.H., dated August 28, 2001
Selengkapnya di halaman GOOD →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
